NY‐ESO‐1 protein expression and humoral immune responses in prostate cancer

Molecular cloning: A laboratory manual

1990 • 85,659 citations

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1991 • 3,493 citations

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1997 • 1,235 citations

Human neoplasms elicit multiple specific immune responses in the autologous host.

1995 • 1,097 citations

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

2002 • 851 citations

Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines

1994 • 841 citations

A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

1998 • 712 citations

DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich Promoter

1999 • 589 citations

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers

2000 • 435 citations

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

2001 • 351 citations

Fingerprinting the circulating repertoire of antibodies from cancer patients

2002 • 334 citations

Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma

2002 • 308 citations

LAGE-1, a new gene with tumor specificity

1998 • 268 citations

Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events

1999 • 230 citations

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes.

1995 • 208 citations

Genes encoding tumor-specific antigens are expressed in human myeloma cells

1999 • 201 citations

Survey of naturally occurring CD4 ⁺ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

2003 • 201 citations

Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.

1999 • 167 citations

A Pathogenic Role of Th2 Cells and Their Cytokine Products on the Pulmonary Metastasis of Murine B16 Melanoma

1998 • 166 citations

CYTOKINE VARIATIONS IN PATIENTS WITH HORMONE TREATED PROSTATE CANCER

2000 • 141 citations

MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression.

2000 • 122 citations

MAGE-B5, MAGE-B6, MAGE-C2, andMAGE-C3: four new members of theMAGE family with tumor-specific expression

2000 • 95 citations

Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma

1999 • 88 citations

NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens

2000 • 77 citations

Anticancer Antibodies

2003 • 73 citations

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

2001 • 69 citations

Exploitation of the B cell repertoire for the identification of human tumor antigens

2000 • 44 citations

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

2000 • 30 citations

Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells

2003 • 26 citations

Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors

2000 • 18 citations

Breakdown of Th Cell Immune Responses and Steroidogenic CYP11A1 Expression in CD4+ T Cells in a Murine Model Implanted with B16 Melanoma

2000 • 16 citations